Press release
Global Cancer Immunotherapy Market & Clinical Trials Outlook 2025
For Report Sample Contact: neeraj@kuickresearch.com
Immunotherapy: Mending Cancer Regimens
1.1 Preface to Cancer Immunotherapy
1.2 Evolution of Cancer Immunotherapy
Categorization of Cancer Immunotherapy
2.1 Specific Cancer Immunotherapy
2.1.1 Cancer Vaccines
2.1.2 Monoclonal Antibodies
2.2 Non-Specific Cancer Immunotherapy
2.2.1 Adoptive Cell Transfer Immunotherapy
2.2.2 Immune Checkpoint Inhibitors
Fundamentals of Cancer Vaccines
3.1 Prologue of Cancer Vaccines
3.2 Cancer Vaccines in Immunotherapy
3.3 Commercial Aspects of Cancer Vaccines
New Era of Monoclonal Antibodies
4.1 Rudiments of Monoclonal Antibodies
4.2 Advents of Monoclonal Antibodies
4.3 Commercial Aspects of Monoclonal Antibodies
Trails of T-Cell Therapies
5.1 Adoptive Cell Transfer Technology
5.2 Strategies of Adoptive Cell Transfer
5.3 Commercial Aspects of Adoptive Cell Therapy
Aspects of Immune Checkpoint Inhibitors
6.1 Prelude to Immune Checkpoint Inhibitors
6.2 Implications of Immunecheck Point Inhibitors
6.3 Commercial Aspects of Immune Checkpoint Inhibitors
Immunomodulators in Cancer Immunotherapy
7.1 Perspective of Immunomodulators
7.2 Clinical Aspects of Immunomodulators
7.3 Commercial Aspects of Immunomodulators
Oncolytic Viral Immunotherapy
8.1 Concept to Oncolytic Viruses
8.2 Potential Approaches of Oncolytic Viruses
8.3 Commercial Aspects of Oncolytic Viruses
Cytokines in Cancer Immunotherapy
9.1 Fundamentals of Cytokines
9.2 Classification of Cytokines
9.3 Commercial Aspects of Cytokines
Interferons in Immunotherapy
10.1 Potentials of Interferons
10.2 Classification of Interferons
10.3 Clinical Applications of Interferons
Interleukins in Immunotherapy
11.1 Potentials of Interleukins
11.2 Clinical Applications of Interleukins
GM-CSF in Immunotherapy
12.1 Potentials of GM-CSF
12.2 Clinical Applications of GM-CSF
Global Economic Evaluations
13.1 Economic Aspects of Cancer Immunotherapy
13.2 Cancer Immunotherapy Cost by Product
Market Aspects of Cancer Immunotherapy
14.1 Current Market Trends
14.2 Cancer Immunotherapy Pipeline Overview
Global Cancer Immunotherapy Market Dynamics
15.1 Favorable Market Parameters
15.2 Commercialization Challenges
Marketed Cancer Cell Therapies Drugs
16.1 Sipuleucel-T (Provenge®)
16.2 T-Lymphocyte Cell Therapy(Immuncell-LC®)
Marketed Cancer Cytokines Drugs
17.1 Aldesleukin (Proleukin®)
17.2 Denileukin Diftitox (ONTAK®)
17.3 Interferon Alpha (Multiferon®)
17.4 Interferon Alpha-2a (Roferon-A®)
17.5 Interferon Alpha-2a (Veldona®)
17.6 Interferon Alpha-2a Biosimilar(Inferon™/Inmutag™)
17.7 Interferon Alpha-2b(Intron® A)
17.8 Interferon Alpha-2b Biosimilar(Bioferon™)
17.9 Interferon Alpha-2b Biosimilar (Intalfa®)
17.10 Interferon Alpha-2b Biosimilar
17.11 Interferon-Alpha-n3 (Alferon N®)
17.12 Interferon-Beta-1b (Feron®)
17.13 Interferon-Gamma (Ogamma®)
17.14 Interleukin-2 Biosimilar (Ilcass)
17.15 Teceleukin (Imunace™)
Marketed Cancer Vaccines
18.1 Bladder Cancer Vaccine (PACIS®)
18.2 Bladder Cancer Vaccine
18.3 BV NSCLC 001
18.4 Dendritic Cell Vaccine (CreaVax-HCC®, CreaVax-PC® & CreaVax-RCC®)
18.5 Human Papillomavirus Vaccine Quadrivalent (Gardasil®/Silgard®)
18.6 Human Papillomavirus Vaccine Recombinant Bivalent (Cervarix®)
18.7 Melanoma Vaccine (MVax®)
18.8 Melanoma Vaccine (Melacine®)
18.9 Racotumomab (Vaxira®)
18.10 Sipuleucel-T (Provenge®)
18.11 Tertomotide (LucaVax)
18.12 Vitespen (Oncophage®)
Marketed Cancer Monoclonal Antibodies
19.1 Bevacizumab
19.2 Trastuzumab Emtansine
19.3 Trastuzumab Subcutaneous
19.4 Brentuximab Vedotin
19.5 Catumaxomab
19.6 Ipilimumab
19.7 Nivolumab
19.8 Pembrolizumab
19.9 Pertuzumab
19.10 Rituximab
19.11 Trastuzumab
Global Cancer Immunotherapy Market Future Prospects
Competitive Landscape
21.1 Abbvie
21.2 Advaxis
21.3 Altor BioScience
21.4 Amgen
21.5 Biogen Idec
21.6 Biogenomics
21.7 Celldex Therapeutics
21.8 Dendreon Corporation
21.9 Eli Lilly
21.10 Expression Genetics
21.11 Galena Biopharma
21.12 Genmab
21.13 Gilead Sciences
21.14 GlaxoSmithKline
21.15 ImmunoCellular Therapeutics
21.16 ImmunoGen
21.17 Inovio Pharmaceuticals
21.18 IRX Therapeutics
21.19 Merck
21.20 NeoStem Oncology
21.21 NewLink Genetics
21.22 Northwest Biotherapeutics
21.23 Novartis
21.24 Peregrine Pharmaceuticals
21.25 Pfizer
21.26 Philogen
21.27 Regulon
21.28 Roche
21.29 Seattle Genetics
21.30 ZymoGenetics
Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.
Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
New Delhi – 110 001, India
+91-11-47067990
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cancer Immunotherapy Market & Clinical Trials Outlook 2025 here
News-ID: 1453451 • Views: …
More Releases from KuicK Research
Multispecific Antibodies Clinical Trials By Indication Country Company Drug Clas …
Global Multispecific Antibodies Market, Drug Sales, Dosage, Price and Clinical Trials Insight 2030 Report Highlights:
• Global Multispecific Antibodies Market Opportunity By 2030: > USD 50 Billion
• Global Multispecific Antibodies Market Sales In 2024: > USD 12 Billion
• Number Of Approved Multispecific Antibodies: 18
• Global and Regional Trends Insight
• Approved Antibodies Global, Regional, Annual and Quarterly Sales Insight
• Approved Antibodies Dosage and Pricing Insight
• Comprehensive Insight On All Antibodies In Clinical…
Gamma Delta T Cell Cancer Therapy Market Opportunity Clinical Trials Technology …
Global Gamma Delta T Cell Cancer Therapy Market Opportunity and Clinical Trials Insight 2030 Report Conclusions:
• Number Of Gamma Delta T Cell Therapies In Trials: > 30 Therapies
• US & China Dominating Clinical Trials Landscape: > 20 Therapies
• Global Gamma Delta T Cell Therapy Clinical Trials Insight By Company, Country, Indication and Phase
• Gamma Delta T Cell Therapy Future Market Opportunity By Different Cancers
• Insight On Clinical Platforms for Evolving…
US Orphan Drugs Market Sales Clinical Trials Insight 2030
US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights:
• US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030
• Insight On FDA Designated Orphan Drugs In Clinical Trials: > 850 Orphan Drugs
• Clinical Trials Insight By Company, Indication, Phase and Priority Status
• Insight On FDA Designated Marketed Orphan Drugs: > 500 Orphan Drugs
• Pricing and Dosage Insight: > 400 Marketed Orphan Drugs
• US, Global,…
US Orphan Drug Market Size Forecast 20230
US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights:
• US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030
• Insight On FDA Designated Orphan Drugs In Clinical Trials: > 850 Orphan Drugs
• Clinical Trials Insight By Company, Indication, Phase and Priority Status
• Insight On FDA Designated Marketed Orphan Drugs: > 500 Orphan Drugs
• Pricing and Dosage Insight: >…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
